Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. IBEX
IBEX logo

IBEX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ibex Ltd (IBEX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
28.850
1 Day change
0.80%
52 Week Range
42.990
Analysis Updated At
2026/03/13
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

IBEX Ltd is not an ideal buy for a beginner, long-term investor at the moment. While the company has shown strong financial growth in the latest quarter, the lack of positive trading signals, insider selling activity, and absence of recent news or catalysts make it less compelling for immediate investment. The technical indicators and options data suggest a neutral to slightly bearish sentiment, and there are no strong signals to support a buy decision right now.

Technical Analysis

The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 34.313, and moving averages are converging, showing no clear trend. The stock is trading near its support level of 28.602, with resistance at 30.359. Overall, the technical indicators suggest a neutral outlook.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate minimal options activity and a lack of strong trading sentiment.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
0

Positive Catalysts

  • Strong financial performance in Q2 2026, with revenue up 16.73% YoY, net income up 31.82% YoY, and EPS up 48.21% YoY.

Neutral/Negative Catalysts

  • Insider selling has increased by 107.94% in the last month, indicating potential lack of confidence from insiders. No recent news or event-driven catalysts. Gross margin dropped by 2.47% YoY.

Financial Performance

In Q2 2026, IBEX showed strong financial growth with revenue increasing to $164.22M (up 16.73% YoY), net income rising to $12.22M (up 31.82% YoY), and EPS growing to $0.83 (up 48.21% YoY). However, gross margin declined to 26.09% (down 2.47% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data on analyst ratings or price target changes is available for IBEX at this time.

Wall Street analysts forecast IBEX stock price to rise
2 Analyst Rating
Wall Street analysts forecast IBEX stock price to rise
0 Buy
2 Hold
0 Sell
Hold
Current: 28.620
sliders
Low
40
Averages
41
High
42
Current: 28.620
sliders
Low
40
Averages
41
High
42
Baird
David Koning
Outperform -> Neutral
downgrade
$30
AI Analysis
2025-05-12
Reason
Baird
David Koning
Price Target
$30
AI Analysis
2025-05-12
downgrade
Outperform -> Neutral
Reason
Baird analyst David Koning downgraded Ibex to Neutral from Outperform with an unchanged price target of $30. The firm views the stock's risk/reward as balanced following a "very strong valuation re-rating over the past year." Ibex has executed very well, returning to double-digit growth in the March quarter, but the stock's risk/reward is balanced, the analyst tells investors in a research note.

People Also Watch